Organization | Fondo Nacional de Desarrollo Científico y Tecnológico, Chile

Fondo Nacional de Desarrollo Científico y Tecnológico, Chile Report issue

Government Phase 1 Phase 2 Phase 3 Phase 4

Founded: Santiago Chile (1984)

Organization Overview

First Clinical Trial

2006

NCT00749645

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2022

Timeline

NOW

Now

Alternative names

Fondo Nacional de Desarrollo Científico y Tecnológico, Chile | Fondo Nacional de Desarrollo Científico y Tecnológico, FONDECYT (Chile).

Active Ingredients

Drugs in Phase 4 Trials (1)

colistin (1 trial)

Drugs in Phase 3 Trials (3)

mycophenolate (CellCept) (1 trial)

prednisone (meticorten) (1 trial)

tacrolimus (prograf) (1 trial)

Drugs in Phase 2 Trials (3)

colchicine (colbenemid) (1 trial)

fang(30) (1 trial)

trimetazidine (1 trial)

Drugs in Phase 1 Trials (1)

dextrose (1 trial)

Drugs in Other Trials (6)

amoxicillin (1 trial)

clarithromycin (biaxin) (1 trial)

fatty acid (1 trial)

lansoprazole (prevacid) (1 trial)

metronidazole (flagyl) (1 trial)

nicotinamide (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Arthritis (Phase 2)

Arthritis, Rheumatoid (Phase 2)

Bacterial Infections (Phase 4)

Gram-Negative Bacterial Infections (Phase 4)

Hypertension (Phase 2)

Kidney Diseases (Phase 3)

Overview

Highest Phase: Phase 4
# of Trials: 9
# of Trial APIs: 14